Free tool
Stocks above their 200-day average
We cover 182 companies trading above their own 200-day average. The median market value in the group is $3.85B. Across the group, the median move over the past trading day is −0.07%. 100% of the 182 with a 200-day average trade above it. Price change over the past year runs from −8.2% to +281.2% across the middle 80 percent of the group, with a median of +52.5%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
182 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | $14.50 | +16.75% | +26.53% | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $151.50 | +10.71% | +73.78% | +146.62% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| OSCR | Oscar Health, Inc. | $31.24 | −0.51% | +108.68% | +83.55% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| WDH1.DE | Demant A/S | 39.10 EUR | +2.84% | +36.62% | −5.53% |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.63% | +29.07% | +30.59% |
| PCVX | Vaxcyte, Inc. | $61.09 | +11.89% | +31.49% | +99.97% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| BRKR | Bruker Corporation | $57.06 | −9.30% | +18.78% | +70.56% |
| ATR | AptarGroup, Inc. | $135.24 | −1.52% | +11.23% | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | 2,613.00 JPY | −3.33% | +3.94% | +4.01% |
| 4523.T | Eisai Co., Ltd. | 4,792.00 JPY | −6.22% | +1.75% | +7.64% |
| TGTX | TG Therapeutics, Inc. Common Stock | $55.03 | +0.29% | +87.94% | +92.61% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% |
| ALKS | Alkermes plc | $49.16 | −2.65% | +73.96% | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $93.61 | −6.36% | +206.10% | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $111.87 | +3.54% | +6.53% | +9.35% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,462.50 JPY | −1.16% | +14.31% | +54.43% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% |
| PACS | PACS Group, Inc. | $44.39 | −5.47% | +12.35% | +274.28% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% |
| 7747.T | Asahi Intecc Co., Ltd. | 3,876.00 JPY | +4.76% | +30.59% | +53.99% |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $99.44 | +9.94% | +251.75% | +555.07% |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | 2,575.00 JPY | −4.35% | −4.12% | −14.74% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| BLTE | Belite Bio, Inc | $156.69 | +0.47% | −1.62% | +144.07% |
| LQDA | Liquidia Corporation | $71.36 | −17.81% | +127.26% | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.99 | −4.10% | +42.10% | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $63.79 | −1.77% | +43.38% | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | 24.00 CAD | +2.61% | +5.31% | +19.34% |
| BLCO | Bausch + Lomb Corporation | $17.25 | +3.85% | +4.04% | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $110.76 | +9.01% | +179.13% | +356.93% |
| STVN | Stevanato Group S.p.A. | $22.38 | +11.07% | +8.75% | −0.09% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% |
| RDNT | RadNet, Inc. | $76.47 | +20.96% | +7.78% | +7.27% |
| CTEC.L | Convatec Group PLC | 228.80 GBP | −0.78% | −4.49% | −1.95% |
| T1FX34.SA | Teleflex Incorporated | 69.78 BRL | 0.00% | +3.04% | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.51 | −12.22% | +26.18% | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $43.77 | +4.31% | +220.89% | +344.37% |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $287.85 | −2.85% | +51.41% | +80.92% |
| CRSP | CRISPR Therapeutics AG | $59.23 | +24.56% | +10.15% | +10.65% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $44.38 | +9.99% | +86.86% | +207.13% |
| LFST | LifeStance Health Group, Inc. | $12.15 | +8.10% | +74.57% | +121.31% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | 503,000.00 KRW | +56.21% | +13.96% | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,640.00 GBP | +0.61% | +7.71% | −9.62% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| ICUI | ICU Medical, Inc. | $179.59 | +8.33% | +29.64% | +41.83% |
| NVST | Envista Holdings Corporation | $27.80 | +3.12% | +28.17% | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% |
| LIVN | LivaNova PLC | $79.97 | −2.58% | +31.88% | +41.56% |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $35.83 | −12.60% | +0.27% | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| ANN.AX | Ansell Limited | 40.00 AUD | +18.89% | +14.92% | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $34.38 | +1.54% | −2.94% | +29.15% |
| DNLI | Denali Therapeutics Inc. | $24.57 | +2.16% | +51.01% | +57.50% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| TLX.AX | Telix Pharmaceuticals Limited | 15.68 AUD | +8.14% | +38.03% | +4.88% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| TLX | Telix Pharmaceuticals Limited | $11.13 | +9.22% | +46.06% | −8.02% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | 1,851.50 JPY | −8.36% | +13.69% | +21.45% |
| 7459.T | MediPal Holdings Corporation | 2,893.50 JPY | −5.56% | +4.92% | +13.38% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| QURE | uniQure N.V. | $50.95 | +38.98% | +117.83% | +223.49% |
| NHC | National HealthCare Corporation | $225.09 | −2.56% | +73.28% | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| MBX | MBX Biosciences, Inc. | $66.76 | +11.16% | +118.53% | +366.53% |
| BEAM | Beam Therapeutics Inc. | $30.19 | +14.83% | +11.24% | +79.06% |
| AFX.DE | Carl Zeiss Meditec AG | 31.92 EUR | +6.33% | −17.62% | −24.83% |
| CLDX | Celldex Therapeutics, Inc. | $40.57 | +14.02% | +50.20% | +79.51% |
| IRON | Disc Medicine, Inc. | $82.67 | +10.74% | +4.53% | +37.90% |
| WRBY | Warby Parker Inc. | $25.48 | −2.00% | +12.64% | −3.96% |
| TARS | Tarsus Pharmaceuticals, Inc. | $70.65 | +19.85% | −12.53% | +22.19% |
| ALMS | Alumis Inc. | $23.62 | −12.62% | +163.76% | +380.08% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| ACHC | Acadia Healthcare Company, Inc. | $30.58 | −6.45% | +114.00% | +37.81% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $24.26 | +24.35% | −20.93% | +30.71% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.44 | +1.77% | +12.03% | −12.10% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| BHVN | Biohaven Ltd. | $16.95 | +23.09% | +56.37% | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $17.92 | −2.77% | +50.71% | +124.00% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| NKTR | Nektar Therapeutics | $73.77 | +4.24% | +69.90% | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +0.92% | +31.07% | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | 13.16 CAD | +8.58% | +267.60% | +197.74% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| KOD | Kodiak Sciences Inc. | $39.33 | −2.38% | +51.15% | +321.09% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| NUVB | Nuvation Bio Inc. | $6.96 | +4.04% | −18.88% | +135.93% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% |
| BHC | Bausch Health Companies Inc. | $6.51 | +44.03% | −9.71% | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | 9.03 CAD | +41.09% | −8.97% | −9.88% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| OCUL | Ocular Therapeutix, Inc. | $10.77 | +27.46% | −8.88% | −12.58% |
| GRDN | Guardian Pharmacy Services, Inc. | $37.48 | −10.46% | +26.92% | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | 64,000.00 KRW | +53.48% | +51.66% | +112.62% |
| UFPT | UFP Technologies, Inc. | $304.57 | +18.02% | +36.33% | +41.94% |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| BFLY | Butterfly Network, Inc. | $8.64 | +20.50% | +130.40% | +450.32% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% |
| CLOV | Clover Health Investments, Corp. | $4.25 | −1.96% | +76.35% | +57.99% |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.54 | +10.56% | +7.75% | +36.58% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% |
| EXE.TO | Extendicare Inc. | 31.68 CAD | −17.40% | +51.30% | +146.56% |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% |
| ZBIO | Zenas BioPharma, Inc. | $33.04 | +2.32% | −4.23% | +97.73% |
| CLOV34.SA | Clover Health Investments, Corp. | 20.84 BRL | −7.01% | +57.16% | +45.23% |
| STOK | Stoke Therapeutics, Inc. | $33.09 | +12.59% | +7.09% | +71.45% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| 008930.KS | Hanmi Science Co., Ltd. | 43,400.00 KRW | +29.36% | +19.84% | +2.80% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.99 | −5.56% | +25.06% | −13.45% |
| CMPS | COMPASS Pathways plc | $14.61 | +34.65% | +123.05% | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.